Search

Your search keyword '"Chizoba Nwankwo"' showing total 68 results
Start Over Author "Chizoba Nwankwo"
68 results on '"Chizoba Nwankwo"'

51. Descriptive Analysis of Drug Utilization among Chronic Hepatitis C Virus (Chc) Patients in the Us Commercially Insured Population

Author

Dongmu Zhang, Chizoba Nwankwo, A Puenpatom, and E Burrell

Subjects
Drug Utilization, medicine.medical_specialty, education.field_of_study, Descriptive statistics, business.industry, Health Policy, Population, Public Health, Environmental and Occupational Health, Virology, Virus, Chronic hepatitis, Internal medicine, medicine, business, education
Published
2015
Full Text
View/download PDF

52. C-Edge Co-Star: Favorable Impact of Elbasvir and Grazoprevir on Health-Related Quality of Life in Treatment-Naïve HCV-Infected Persons who Inject Drugs Receiving Opioid Agonist Therapy

Author

Gregory J. Dore, Oren Shibolet, Z. Jiang, Alain H. Litwin, Frederick L. Altice, Heather L. Platt, J. Grebeley, T.C. Mast, I.N. Gendrano, Chizoba Nwankwo, and J.M. Arduino

Subjects
Health related quality of life, medicine.medical_specialty, Elbasvir, Hepatology, business.industry, Pharmacology, Therapy naive, 03 medical and health sciences, 0302 clinical medicine, Grazoprevir, Opioid Agonist, 030220 oncology & carcinogenesis, Internal medicine, Medicine, 030211 gastroenterology & hepatology, business
Published
2016
Full Text
View/download PDF

56. Cost-Effectiveness of Elbasvir (EBR, MK-8742)/Grazoprevir (GZR, MK-5172) Use in Treatment-Naive and Treatment-Experienced Patients with Hepatitis C Virus (HCV) Genotype 1 Infection and Chronic Kidney Disease (CKD) in the United States

Author

W. Greaves, Elamin H. Elbasha, and Chizoba Nwankwo

Subjects
Elbasvir, Hepatology, Cost effectiveness, business.industry, Hepatitis C virus, medicine.disease_cause, medicine.disease, Virology, Treatment experienced, Therapy naive, Hcv genotype 1, Grazoprevir, medicine, business, Kidney disease
Published
2016
Full Text
View/download PDF

60. FP693HEPATITIS C INFECTION IN HEMODIALYSIS PATIENTS IS ASSOCIATED WITH INFERIOR QUALITY OF LIFE IN THE DOPPS

Author

David A. Goodkin, Brian Bieber, Jean Marie Arduino, Eiichiro Kanda, Ronald L. Pisoni, Michel Jadoul, and Chizoba Nwankwo

Subjects
Transplantation, medicine.medical_specialty, Quality of life (healthcare), Nephrology, business.industry, medicine.medical_treatment, medicine, Hepatitis C, Hemodialysis, medicine.disease, Intensive care medicine, business
Published
2015
Full Text
View/download PDF

64. The Health and Economic Impact of a Quadrivalent Human Papillomavirus Vaccine (6/11/16/18) in Columbia: A Transmission Dynamic Model-Based Evaluation

Author

H. Posso, S. Kothari, M. Pillsbury, A. Shcheprov, and Chizoba Nwankwo

Subjects
Transmission dynamic, business.industry, Health Policy, Environmental health, Public Health, Environmental and Occupational Health, Medicine, Economic impact analysis, Human papillomavirus vaccine, business, Virology
Published
2013
Full Text
View/download PDF

65. Development And External Validation Of A Risk Calculator For Predicting Anemia In Patients Treated With Triple Therapy (Tt) Containing Boceprevir (Boc), Pegylated Interferon And Ribavirin (Pr)

Author

A. Luan, Chizoba Nwankwo, Michael W. Kattan, and J. Wahl

Subjects
Oncology, medicine.medical_specialty, Anemia, business.industry, Health Policy, Ribavirin, Public Health, Environmental and Occupational Health, External validation, medicine.disease, Virology, chemistry.chemical_compound, chemistry, Pegylated interferon, Internal medicine, Boceprevir, medicine, In patient, business, medicine.drug
Published
2014
Full Text
View/download PDF

67. Public health impact and cost effectiveness of hepatitis a vaccination in the united states: A population-based dynamic model

Author

Camilo J. Acosta, Michelle G. Goveia, Elamin H. Elbasha, M. Pillsbury, Andreas Lauschke, Praveen Dhankhar, and Chizoba Nwankwo

Subjects
medicine.medical_specialty, business.industry, Cost effectiveness, Health Policy, Environmental health, Public health, Public Health, Environmental and Occupational Health, Medicine, Hepatitis A vaccination, Population based, business
Published
2013
Full Text
View/download PDF

68. Clinically meaningful differences in health-related quality of life and fatigue in patients with hepatitis C virus infection treated with elbasvir/grazoprevir compared to sofosbuvir with pegylated interferon and ribavirin

Author

Shelby Corman, Jean Marie Arduino, Jan Sperl, S. Patel, B. King-Kallimanis, Chizoba Nwankwo, Heather L. Platt, and Jingjun Qiu

Subjects
Health related quality of life, Hepatology, Sofosbuvir, business.industry, Ribavirin, Hepatitis C virus, medicine.disease_cause, Virology, chemistry.chemical_compound, chemistry, Pegylated interferon, medicine, Elbasvir, Grazoprevir, In patient, business, medicine.drug

Catalog

Books, media, physical & digital resources
See catalog results